Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | RIPK1 | Q13546 | 2/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.30 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
| ▸ | PTPRZ1 | P23471 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10351871 | 0.98 | ALDH1A1 (0.37) | ALDH1A1MAPK1POLBMAPTHPGD | |
| SCHEMBL14430941 | 0.77 | ALDH1A1 (0.39) | ALDH1A1MAPK1MAPTHPGDSMN1; SMN2 | |
| SCHEMBL199652 | 0.77 | SHBG (0.50) | ALDH1A1MAPTHPGDHSD17B10CYP3A4 | |
| SCHEMBL199651 | 0.77 | SLC6A4 (0.32) | — | |
| SCHEMBL10352481 | 0.77 | SLC6A4 (0.36) | ALDH1A1POLBMAPTCYP1A2CYP3A4 | |
| SCHEMBL2950715 | 0.76 | ALDH1A1 (0.37) | ALDH1A1MAPK1POLBMAPTHPGD | |
| SCHEMBL776173 | 0.76 | ALDH1A1 (0.37) | ALDH1A1MAPK1MAPTHPGDSMN1; SMN2 | |
| SCHEMBL3935115 | 0.76 | ALDH1A1 (0.37) | ALDH1A1MAPK1POLBMAPTHPGD | |
| SCHEMBL2945120 | 0.76 | CYP1A2 (0.53) | ALDH1A1MAPK1MAPTHPGDSMN1; SMN2 | |
| SCHEMBL1454164 | 0.74 | ALDH1A1 (0.36) | ALDH1A1MAPK1MAPTHPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 306 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3443055-B1 | REMOVING AROMATIC COMPOUNDS FROM A HYDROCARBON FLUID | CASTROL LTD (GB) | 2024-07-03 | — | — | EP | disclosed |
| EP-3253852-B1 | USE OF A HYDROCARBYL-SUBSTITUTED SALICYLIC ACID DETERGENT AS AN INHIBITOR OF LEAD CORROSION | CASTROL LTD (GB) | 2024-06-19 | — | — | EP | disclosed |
| EP-3697750-B1 | SELECTIVE ACETALIZATION / ETHERIFICATION PROCESS | BP PLC (GB) | 2024-02-14 | — | — | EP | disclosed |
| EP-3583195-B1 | ETHERIFICATION PROCESS, PROCESS FOR PREPARING A LUBRICANT COMPOSITION AND PROCESS FOR LUBRICATING A SURFACE | BP PLC (GB) | 2023-12-20 | — | — | EP | disclosed |
| EP-3883913-B1 | PROCESS FOR MAKING ETHERS VIA ENOL ETHERS | BP PLC (GB) | 2023-11-01 | — | — | EP | disclosed |
| CN-113272269-B | Process for preparing ethers via enol ethers | 英国石油有限公司 | 2023-10-20 | — | — | CN | disclosed |
| US-11787760-B2 | Process for making ethers via enol ethers | BP P.L.C. (GB) | 2023-10-17 | — | — | US | disclosed |
| EP-3746529-B1 | LUBRICANT COMPOSITION | CASTROL LTD (GB) | 2023-07-12 | — | — | EP | disclosed |
| CN-111511710-B | Selective acetalization/etherification process | 英国石油有限公司 | 2023-05-16 | — | — | CN | disclosed |
| CN-115992021-A | Use of boron-containing additives as lead corrosion inhibitors | 卡斯特罗尔有限公司 | 2023-04-21 | — | — | CN | disclosed |
| EP-0294096-A1 | Improved process for preparing stable oleaginous compositions | EXXON CHEMICAL PATENTS INC. (US) | 1988-12-07 | — | — | EP | disclosed |
| EP-0288324-A2 | Novel dispersants for oleaginous compositions | EXXON CHEMICAL PATENTS INC. (US) | 1988-10-26 | — | — | EP | disclosed |
| US-4776969-A | WEAR RESISTANT, OXIDATIN RESISTANCE AND FRICTION MODIFYING OIL ADDITIVES | EXXON CHEMICAL PATENTS INC. (US) | 1988-10-11 | — | — | US | disclosed |
| US-4772406-A | OIL ADDITIVES; HEAT AND OXIDATION RESISTANCE | EXXON CHEMICAL PATENTS INC. (US) | 1988-09-20 | — | — | US | disclosed |
| EP-0264247-A2 | High functionality low molecular weight oil soluble dispersant additive useful in oleaginous compositions | EXXON CHEMICAL PATENTS INC. (US) | 1988-04-20 | — | — | EP | disclosed |
| EP-0263704-A2 | Lactone modified, aminated dispersant additives useful in oleaginous compositions | EXXON CHEMICAL PATENTS INC. (US) | 1988-04-13 | — | — | EP | disclosed |
| EP-0263703-A2 | Lactone modified, esterified or aminated additives useful in oleaginous compositions | EXXON CHEMICAL PATENTS INC. (US) | 1988-04-13 | — | — | EP | disclosed |
| EP-0263706-A2 | Adducts or reactants modified with a lactone and oleaginous compositions containing same | EXXON CHEMICAL PATENTS INC. (US) | 1988-04-13 | — | — | EP | disclosed |
| EP-0263702-A2 | Lactone modified, esterified dispersant additives useful in oleaginous compositions | EXXON CHEMICAL PATENTS INC. (US) | 1988-04-13 | — | — | EP | disclosed |
| EP-0240327-A2 | Cyclic phosphate additives and their use in oleaginous compositions | EXXON CHEMICAL PATENTS INC. (US) | 1987-10-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11787760-B2 | Process for making ethers via enol ethers | ELOVL5, ELOVL1, ELOVL3 | ALDH1A1 124/4885MAPK1 2394/4885POLB 998/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.